Author/Authors :
Shahbazi، Sh نويسنده Shiraz Anesthesiology and Critical Care Research Center, Shiraz, IR Iran , , Zeighami، D نويسنده Shiraz Anesthesiology and Critical Care Research Center, Shiraz, IR Iran , , Allahyary، E نويسنده Shiraz Anesthesiology and Critical Care Research Center, Shiraz, IR Iran , , Alipour، A نويسنده Epidemiologic Department , Nutrition and Health School, Shiraz University of Medical Sciences, Shiraz, IR Iran , , Esmaeeli، MJ نويسنده Shiraz Anesthesiology and Critical Care Research Center, Shiraz, IR Iran , , Ghaneie ، M نويسنده Shiraz Anesthesiology and Critical Care Research Center, Shiraz, IR Iran ,
Abstract :
Background: We evaluated the effects of tissue and organ perfusion during and after coronary artery bypass graft surgery with either colloid (Voluven) or crystalloid (Lactated ringer’s) as prime solution.
Methods: In this prospective randomized-controlled trial study, 70 patients undergoing on-pump coronary artery bypass graft surgery were randomly assigned to receive either colloid (Voluven) or crystalloid (Lactated ringer’s) as prime solution, for initiation of cardiopulmonary bypass machine procedure. Tissue and organ perfusion markers including lactate, troponin I, liver and renal function tests and electrolytes were measured sequentially, before induction (T1) to second days after surgery (T5).
Results: With exception of chloride and potassium levels no significant differences detected in other measurements, and the laboratory results were entirely identical in both procedures.
Conclusion: There was no significant difference between Voluven® ( hydroxyethyl starch, HES 130/0.4) and crystalloid (Lactated ringer’s) as priming solution on the basis of organ and tissue perfusion tests assessment.
